Broderick Brian C Ironwood Pharmaceuticals Inc Transaction History

Broderick Brian C

$463 Million
Q2 2025

A detailed history of Broderick Brian C transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Broderick Brian C holds 18,000 shares of IRWD stock, worth $27,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,000

Previous 33,000 45.45%

Holding current value

$27,000

Previous $48,000 75.0%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$0.57 - $1.44 $8,550 - $21,600	-15,000 Reduced 45.45%	18,000 $12,000
Q2 2024 Aug 12, 2024	SELL	$5.58 - $8.61 $16,740 - $25,830	-3,000 Reduced 8.33%	33,000 $215,000
Q2 2023 Aug 11, 2023	SELL	$10.1 - $11.6 $10,100 - $11,600	-1,000 Reduced 2.7%	36,000 $383,000
Q1 2023 May 10, 2023	SELL	$10.37 - $12.56 $435,539 - $527,520	-42,000 Reduced 53.16%	37,000 $389,000
Q3 2022 Nov 08, 2022	SELL	$10.14 - $12.38 $45,630 - $55,710	-4,500 Reduced 5.39%	79,000 $818,000
Q2 2022 Jul 19, 2022	SELL	$11.05 - $12.72 $138,125 - $159,000	-12,500 Reduced 13.02%	83,500 $963,000
Q1 2022 May 17, 2022	SELL	$10.61 - $12.88 $73,697 - $89,464	-6,946 Reduced 6.75%	96,000 $1.21 Million
Q4 2021 Feb 08, 2022	SELL	$10.86 - $13.95 $417,067 - $535,735	-38,404 Reduced 27.17%	102,946 $1.2 Million
Q3 2021 Nov 10, 2021	SELL	$11.92 - $13.92 $29,800 - $34,800	-2,500 Reduced 1.74%	141,350 $1.85 Million
Q2 2021 Aug 09, 2021	SELL	$10.16 - $13.11 $83,820 - $108,157	-8,250 Reduced 5.42%	143,850 $1.85 Million
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $45,199 - $59,300	-5,000 Reduced 3.18%	152,100 $1.7 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $497,750 - $671,000	55,000 Added 53.87%	157,100 $1.79 Million
Q3 2020 Oct 28, 2020	SELL	$8.99 - $10.74 $13,485 - $16,110	-1,500 Reduced 1.45%	102,100 $918,000
Q1 2020 May 07, 2020	SELL	$8.58 - $14.01 $73,624 - $120,219	-8,581 Reduced 7.65%	103,600 $1.05 Million
Q4 2019 Jan 15, 2020	SELL	$8.22 - $14.0 $1.74 Million - $2.96 Million	-211,691 Reduced 65.36%	112,181 $1.49 Million
Q3 2019 Nov 04, 2019	SELL	$8.59 - $10.96 $46,050 - $58,756	-5,361 Reduced 1.63%	323,872 $2.78 Million
Q3 2018 Oct 15, 2018	SELL	$14.31 - $17.65 $696,897 - $859,554	-48,700 Reduced 12.89%	329,233 $6.08 Million
Q2 2018 Jul 30, 2018	SELL	$11.83 - $16.2 $1.26 Million - $1.73 Million	-106,532 Reduced 21.99%	377,933 $7.23 Million
Q1 2018 Apr 24, 2018	SELL	$11.13 - $13.63 $28,938 - $35,438	-2,600 Reduced 0.53%	484,465 $7.48 Million
Q4 2017 Feb 02, 2018	BUY	$12.16 - $14.58 $4.17 Million - $4.99 Million	342,589 Added 237.13%	487,065 $7.3 Million
Q3 2017 Oct 26, 2017	BUY	$12.07 - $14.87 $1.74 Million - $2.15 Million	144,476	144,476 $2.28 Million

Others Institutions Holding IRWD

# of Institutions

181

Shares Held

158M

Call Options Held

11.2M

Put Options Held

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $230M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broderick Brian C, based on Form 13F filings with the SEC.

News

Stay updated on Broderick Brian C with notifications on news.

Account

Broderick Brian C Ironwood Pharmaceuticals Inc Transaction History